Mirzayeva Kamola Saidrahmanovna

Kafedra dotsenti , t.f.n.

  • Manzil: 100109, Toshkent sh. Forobiy ko’chasi 2
  • Tel.: +998(90)
  • E- mail: kamolamirzayeva@tma.uz

| |

Ta’lim:

  • 1987-1993 yillar – Ikkinchi Toshkent Davlat tibbiyot instituti talabasi
  • 1993-1994 yillar – Ikkinchi Toshkent Davlat tibbiyot instituti asab kasalliklari kafedrasi, ordinatura
  • 1998-2000 yillar – Ikkinchi Toshkent davlat tibbiyot instituti asab kasalliklari kafedrasi klinik ordinaturasi
  • 2000-2003 –Toshkent davlat tibbiyot instituti asab kasalliklari kafedrasi, aspirantura

Mehnat faoliyati:

  • 1994-1998 yillar – 2-Toshkent davlat tibbiyot instituti 2 poliklinika “Reanimatsiya” bo‘limi nevropatologi
  • 2003-2004 yillar –Toshkent davlat tibbiyot instituti asab kasalliklari kafedrasi assistenti
  • 2004-2013 yillar – Toshkent tibbiyot akademiyasi asab kasalliklari kafedrasi assistenti
  • 2013 yil – hozirgi kun Toshkent tibbiyot akademiyasi Nevrologiya va tibbiy psixologiya kafedrasi dotsenti
  • 2018 yildan boshlab “Ezgu Niyat” ko‘p tarmoqli tibbiyot markazi nevropatologi

Ilmiy faoliyat:

  • 2003 yil “Intrakranial giper- va gipotenziv sindromlar bilan kechadigan surunkali xorioependimitning klinik va neyrofiziologik xususiyatlari, tuzatish usullari” nomzodlik dissertatsiyasini himoya qildi.

Asosiy amaliy yo’nalish:

  • Nerv tizimining funksional va organik patologiyasi muammolari
  • O‘zbekiston Respublikasi Milliy antidoping agentligi “Odob-axloq” axloqiy komissiyasi a’zosi

Asosiy ilmiy yo’nalish:

  • Miya qon tomir kasalliklari; Yallig’lanish kasalliklari; Epilepsiya.

Nashr etilgan ilmiy ishlar (oxirgi 5 yil):

Maqolalar:

  • Studying the Causes of Cavernous Sinus Thrombosis at COVID-19 /Journal of education and scientific medicine 2 (4), 2023. Р.71-76
  • Unraveling the genetic aspects of Parkinsonism plus: insights into disease pathogenesis andpotential therapeutic targets DASG /Scientific journal of medical science and biology 1 (1), 2023. Р.2-14
  • Cytokines in the etiopathogenesis of ischemic stroke after COVID-19/SJMSB Medical Science and Biology 2, 2023. Р. 159-163
  • Role of cytokines and thrombophilia genes in the etiopathogenesis of ischemic stroke after COVID-19/ SJMSB Medical Science and Biology 2, 2023. Р.155-158
  • Анализ риска возникновения острого нарушения мозгового кровообращения на фоне беременности /Journal of neurology and neurosurgery research 4 (3), 2023. Р. 38-41
  • Динамика качества жизни при монотерапии некоторыми противоэпилептическими препаратами: сравнительный анализ /Журнал неврологии и нейрохирургических исследований. 2022
  • Comparative analysis of efficiency of some antiepileptic drugs monotherapy with the assessment of the dynamics of quality of life in patients with epilepsy/Journal of the Neurological Sciences 2021
  • Confirmation of the neurovisual significance of asymptomatic transient ischemic attacks in the ischemic stroke and prognosis /International journal of stroke 15 (1_ Suppl), 2020. Р. 450-450
  • Optimization of diagnostic approach to depression in patients with epilepsy and seizure disorders/ Journal of Neurology & Neuroscience, 2019. Page 50,
  • The rolе and meaning of video-EEG monitoring in the diagnosis of temporal lobe epilepsy in women of menopausal age /Journal of Neurology & Neuroscience, 2019. Page 47
  • Confirmation of the neuroimaging significance of asymptomatic transient ischemic attack (TIA) in the course and prognosis of ischemic stroke/BAA Dubai, 2019
  • of some the assessment of the d of with
  • Dynamics of quality of life in epilepsy patients with comparative analysis efficiency antiepileptic drugs monotherapy.  Epilepsia 58, 2017. Р.164-S164
  • Implication of C4d in progression of ischemic stroke on patients with lupus erythematosus/European journal of Neurology 22, 593-593
  • Clinical and MRI-characteristics of drug-induced Parkinsonism in Uzbekistan /Movement disorders 31, 2016. Р289-S290
  • Age and gender features of encephalopathy in lupus erythematosus / Journal of cerebral blood flow and metabolism 36, 2016. Р.747-747
  • Olfactory loss-early non-motor symptom in Parkinson’s disease/Movement disorders 31, 2016. Р.99-S99
  • Implication of CD4 for the progression of Parkinsonism in patients with lupus erythematosus/ Parkinsonism & Related Disorders 22, 2016 e126
  • Медико-психологические аспекты особенностей течения остеохондроза у лиц молодого возраста/ Журнал теоретической и клинической медицины. №2. 2015 С.77-81.

O’quv qo’llanmalari va uslubiy tavsiyalar:

  • Динамика неврологических проявлений COVID-ассоциированного тромбоза кавернозного синуса /Lambert Academy Publishing, 2023

 

Translate: English Russian Uzbek